| CORA HEALTHCARE, INC. Patent applications |
| Patent application number | Title | Published |
|---|
| 20110117586 | Protocol for Risk Stratification of Ischemic Events and Optimized Individualized Treatment - A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit preparation of an individualized assessment of ischemic event risk and individualized treatment of a subject. | 05-19-2011 |
| 20100041081 | Protocol For Risk Stratification of Ischemic Events and Optimized Individualized Treatment - A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit preparation of an individualized assessment of ischemic event risk and individualized treatment of a subject. | 02-18-2010 |
